WTMB Group is an independent research and media company covering AI and technology in drug discovery and pharma R&D.
BioPharmaTrend started in 2016 as a blog on AI in drug discovery, written by two chemistry PhDs from Kyiv, Andrii Buvailo and Oleg Kucheriavyi. It grew into a publication cited by Deloitte, RAND Corporation, the European Parliament and Nature Reviews Drug Discovery.
In 2026 we brought BioPharmaTrend, the Where Tech Meets Bio newsletter and The Biotech Edge together as WTMB Research & Media, based in Spain.
We ask what a company has actually shown, not what its press release claims.
Our editors are scientists. We read the papers, not just the funding news.
Sponsored content is always labelled. Sponsors never buy coverage in our independent analysis.
PhD in physical chemistry. Spent eight years at Enamine as Director of E‑commerce and Marketing. Writes on AI in drug discovery, platform companies and techbio investment. Published in Forbes.
Check out Andrii's website →PhD in physical chemistry.